Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

AIDS Vaccine Candidate Successfully ‘Primes’ Immune System in Mice

June 22, 2015 1:22 pm | by Scripps Research Institute | News | Comments

New research led by scientists at The Scripps Research Institute (TSRI), International AIDS Vaccine Initiative (IAVI) and The Rockefeller University shows in mice that an experimental vaccine candidate designed at TSRI can stimulate the immune system activity necessary to stop HIV infection. The findings could provide key information for the development of an effective AIDS vaccine. Read more...

TOPICS:

Merck Biochemist Arrested, Charged with Running GHB Lab in His Home

June 22, 2015 1:11 pm | by Seth Augenstein, Digital Reporter | News | Comments

A senior biochemist at Merck was arrested last week and charged with running a drug lab at his home, authorities announced. Read more...

TOPICS:

Patent for Pricey Hepatitis C Drug Sovaldi Rejected in China

June 22, 2015 9:01 am | by Ryan Bushey, Associate Editor | Articles | Comments

China is a very lucrative pharmaceutical market, but the company is expected to appeal. Read more...

TOPICS:
Advertisement

Global Search for Next Antibiotic

June 22, 2015 8:31 am | by University of Queensland | News | Comments

Researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics. Read more...

TOPICS:

Tekmira Says Ebola Drug Unlikely to Work in Study

June 22, 2015 8:21 am | by The Associated Press | News | Comments

The Canadian company said the mid-stage study reached a statistical futility boundary. Read more...

TOPICS:

TB Bacteria Hide in Low Oxygen Niches of Bone Marrow Stem Cells

June 22, 2015 8:20 am | by Forsyth Institute | News | Comments

A new study is helping to shed light on latent tuberculosis and the bacteria’s ability to hide in stem cells. Read more...

TOPICS:

Studying the Evolution of Ebola

June 22, 2015 8:20 am | by University of Bristol | News | Comments

The research team used blood samples taken from patients and compared changes in the genetic material of the virus from throughout the outbreak. Read more...

TOPICS:

North Korea Says it Cured Cancer, AIDS, Ebola with Wonder Drug

June 22, 2015 8:20 am | by Seth Augenstein, Digital Reporter | News | Comments

North Korea — which has allegedly starved millions of its people and is unable to treat even modest medical problems such as cataracts — has a new drug on the market that it says can cure AIDS, Ebola and some cancers. Read more...

TOPICS:
Advertisement

GlaxoSmithKline Invests $95M in Independent Genetics Institute

June 19, 2015 1:29 pm | by Seth Augenstein, Digital Reporter | News | Comments

GlaxoSmithKline is investing in probing deep into a human cell’s “operating system,” they announced this week. The London-based pharma company is investing $95 million in a new startup called the Altius Institute for Biomedical Sciences in Seattle, they announced. Read more...

TOPICS:

Selecta's Synthetic Vaccine Particles Instrumental in Mucosal Vaccines Research

June 19, 2015 12:19 pm | News | Comments

Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies using synthetic vaccine particles (SVP), today announced a publication in the prestigious journal Science describing the use of SVP to create a novel vaccine technology designed to target mucosal tissues. Read more...

TOPICS:

Phase 3 Data Show Panitumumab Improves OS in Metastatic Colorectal Cancer

June 19, 2015 11:57 am | News | Comments

Amgen today announced that a Phase 3 study evaluating Vectibix® (panitumumab) and best supportive care (BSC) met its primary endpoint, demonstrating a statistically significant improvement in overall survival (OS) in patients with chemorefractory wild-type KRAS (exon 2) metastatic colorectal cancer (mCRC) compared to those patients treated with BSC alone. Read more...

TOPICS:

NIH Funding to Increase $1.1 B – But Popular Agency is Eliminated

June 19, 2015 11:48 am | by Seth Augenstein, Digital Reporter | News | Comments

The National Institutes of Health would get an additional $1.1 billion in next year’s budget, while eliminating a popular agency, according to a House appropriations bill released this week. Read more...

TOPICS:

Molecular Cause of Heart Condition Identified by Researchers

June 19, 2015 10:55 am | by Krista Conger, Stanford University | News | Comments

The beta adrenergic pathway is dysfunctional in dilated cardiomyopathy. Now, researchers have learned how a mutation that causes the disease affects the pathway, and how to mitigate its effects. Read more...

TOPICS:

U.S. Agrees to Pay Millions for Agent Orange Claims

June 19, 2015 10:46 am | by Hope Yen, Associated Press | News | Comments

Ending years of wait, the government agreed Thursday to provide disability benefits to as many as 2,100 Air Force reservists and active-duty forces exposed to Agent Orange residue on airplanes used in the Vietnam War. Read more...

TOPICS:

MRSA Contamination Found in Supermarket Sausages, Mixed Pork

June 19, 2015 9:39 am | by University of Cambridge | News | Comments

In collaboration with the Wellcome Trust Sanger Institute an analysis of the genetic make-up of the bacteria and confirmed the presence of antibiotic resistant genes. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading